Correlation of Checkerboard Synergy Testing With Time-Kill Analysis and Clinical Outcomes of Extensively Drug-Resistant Acinetobacter Baumannii Respiratory Infections

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00981-16
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter Baumannii Infections

Drugs
Pharmacology
2014English

Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter Baumannii Clinical Isolates

mBio
VirologyMicrobiology
2019English

Synergy Effect of Ceftazidime-Avibactam With Meropenem Against Pan-Resistant Acinetobacter Baumannii and Serratia Marcescens Harboring Carbapenemases: Time-Kill and Disk Approximation Assays

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

In-Vitro Efficacy of Polymyxin B With Rifampin, Colistin and Doxycycline Against Extensively Drug Resistant Acinetobacter Baumannii

African Journal of Microbiology Research
2014English

Clinical Outcomes of Carbapenem-Resistant Acinetobacter Baumannii Bloodstream Infections: Study of a 2-State Monoclonal Outbreak

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
2010English

Successful Treatment of Extensively Drug-Resistant Acinetobacter Baumannii Ventriculitis With Intravenous Plus Intraventricular Tigecycline- A Case Report

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Treatment of Severe Ventriculitis Caused by Extensively Drug-Resistant Acinetobacter Baumannii by Intraventricular Lavage and Administration of Colistin

Infection and Drug Resistance
Infectious DiseasesPharmacology
2019English

Genomic and Proteomic Characterization of Multi-Drug Resistant Acinetobacter Baumannii

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2013English

Clinical Outcomes of Colistin in Combination With Either 6-G Sulbactam or Carbapenems for the Treatment of Extensively Drug-Resistant Acinetobacter Baumannii Pneumonia With High MIC to Sulbactam, a Prospective Cohort Study

Infection and Drug Resistance
Infectious DiseasesPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy